[1] Zimmermann L, Wendt S, Lübbert C, et al. Epidemiology of pyogenic liver abscesses in Germany: analysis of incidence, risk factors and mortality rate based on routine data from statutory health insurance. United European Gastroenterol J, 2021,9(9):1039-1047. [2] Kumar SK, Perween N, Omar BJ, et al. Pyogenic liver abscess: clinical features and microbiological profiles in tertiary care center. J Family Med Prim Care,2020,9(8):4337-4342. [3] 王雪梅,张瑶,杨学平,等.超声引导下经皮肝穿刺抽脓法和置管引流法治疗艾滋病并发肝脓肿患者临床效果分析.实用肝脏病杂志,2021,24(4):573-576. [4] Lardière-Deguelte S, Ragot E, Amroun K, et al. Hepatic abscess: Diagnosis and management. J Visc Surg,2015,152(4):231-243. [5] Song H, Wang X, Lian Y, et al. Analysis of the clinical characteristics of 202 patients with liver abscess associated with diabetes mellitus and biliary tract disease. J Int Med Res,2020,48(8):300060520949404. [6] 张溥,李登科,孙文兵,等.高毒力肺炎克雷伯菌性肝脓肿的研究现状与进展.中华肝胆外科杂志,2020,26(12):949-953. [7] Foo NP, Chen KT, Lin HJ, et al. Characteristics of pyogenic liver abscess patients with and without diabetes mellitus. Am J Gastroenterol,2010,105(2):328-335. [8] Li W, Chen H, Wu S, et al. A comparison of pyogenic liver abscess in patients with or without diabetes: a retrospective study of 246 cases. BMC Gastroenterol, 2018,18(1):144. [9] Lee CH, Jo HG, Cho EY, et al. Maximal diameter of liver abscess independently predicts prolonged hospitalization and poor prognosis in patients with pyogenic liver abscess. BMC Infect Dis,2021,21(1):171. [10] Jindal A, Pandey A, Sharma MK, et al. Management practices and predictors of outcome of liver abscess in adults: a series of 1630 patients from a liver unit. J Clin Exp Hepatol,2021,11(3):312-320. [11] Du Z, Zhou X, Zhao J, et al. Effect of diabetes mellitus on short-term prognosis of 227 pyogenic liver abscess patients after hospitalization. BMC Infect Dis,2020,20(1):145. [12] Myeong JH, Kyoung DS, Park MA, et al. Anaerobe coverage is important for the prognosis of pyogenic liver abscess: a population-based study in Korea. J Infect Public Health,2022,15(4):425-432. [13] Mukthinuthalapati VVPK, Attar BM, Parra-Rodriguez L, et al. Riskfactors, management, and outcomes of pyogenic liver abscess in a US safety net hospital. Dig Dis Sci,2020,65(5):1529-1538. [14] Lee NK, Kim S, Lee JW, et al. CT differentiation of pyogenic liver abscesses caused byKlebsiella pneumoniae vs non-Klebsiella pneumoniae. Br J Radiol,2011, 84(1002):518-525. [15] Lee HL, Lee HC, Guo HR, et al. Clinical significance and mechanism of gas formation of pyogenic liver abscess due to a Klebsiella pneumonie. J Clin Microbiol, 2004,42(6):2783-2785. [16] Lai KC, Cheng KS, Jeng LB, et al. Factors associated with treatment failure of percutaneous catheter drainage for pyogenic liver abscess in patients with hepatobiliary-pancreatic cancer. Am J Surg,2013,205(1):52-57. [17] Miek T, Ciostek P. Percutaneous treatment of liver abscess – outcomes. Prz Gastroenterol,2019,14(2):129-132. [18] 王思琪,申远,崔振兴,等.腹腔镜穿刺置管引流术与腹腔镜切开置管引流术治疗肝脓肿患者疗效观察.实用肝脏病杂志,2022,25(2):283-286. [19] Gao HN, Yuan WX, Yang MF, et al. Clinical significance of C-reactive protein values in antibiotic treatment for pyogenic liver abscess. World J Gastroenterol, 2010,16(38):4871-4875. [20] 黎伟政,黄杰安.消化系统隐匿性恶性肿瘤相关化脓性肝脓肿的研究进展. 中华肝脏病杂志,2021,29(3):275-278. |